Renaissance Technologies - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 100 filers reported holding HARVARD BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$3,202
-22.5%
744,678
-1.0%
0.01%
-16.7%
Q2 2023$4,130
+34.7%
752,207
+3.0%
0.01%
+50.0%
Q1 2023$3,066
+50.7%
730,007
-0.6%
0.00%
+33.3%
Q4 2022$2,034
-99.9%
734,307
-13.8%
0.00%0.0%
Q3 2022$2,180,000
-39.5%
851,466
-15.0%
0.00%
-25.0%
Q2 2022$3,605,000
-38.8%
1,001,262
+5.6%
0.00%
-42.9%
Q1 2022$5,890,000
-7.8%
948,445
+4.7%
0.01%
-12.5%
Q4 2021$6,387,000
-15.0%
905,945
-15.8%
0.01%
-20.0%
Q3 2021$7,514,000
-26.9%
1,076,445
-12.7%
0.01%
-23.1%
Q2 2021$10,274,000
+31.8%
1,233,345
-13.6%
0.01%
+30.0%
Q1 2021$7,795,000
+49.4%
1,427,645
+17.4%
0.01%
+66.7%
Q4 2020$5,219,000
+38.5%
1,216,445
-2.8%
0.01%
+50.0%
Q3 2020$3,767,000
+17.7%
1,251,348
+21.2%
0.00%
+33.3%
Q2 2020$3,200,000
+113.9%
1,032,130
+52.5%
0.00%
+200.0%
Q1 2020$1,496,000
-8.5%
676,830
+26.3%
0.00%0.0%
Q4 2019$1,635,000
+3.2%
536,000
+4.0%
0.00%0.0%
Q3 2019$1,584,000
-12.1%
515,212
-42.8%
0.00%
-50.0%
Q2 2019$1,802,000
-32.7%
901,000
+45.0%
0.00%0.0%
Q1 2019$2,679,000
+20.4%
621,500
-11.2%
0.00%0.0%
Q4 2018$2,226,000
-51.8%
699,910
-20.4%
0.00%
-60.0%
Q3 2018$4,618,000
-40.7%
879,700
-41.5%
0.01%
+25.0%
Q2 2018$7,785,000
+105.6%
1,504,767
+98.7%
0.00%0.0%
Q1 2018$3,786,000
+87.4%
757,299
+23.7%
0.00%
+100.0%
Q4 2017$2,020,000
-11.0%
612,132
+1.2%
0.00%
-33.3%
Q3 2017$2,269,000
+50.9%
605,045
+2.6%
0.00%
+50.0%
Q2 2017$1,504,000
+3.2%
590,000
+5.3%
0.00%0.0%
Q1 2017$1,457,000
-9.7%
560,500
+5.9%
0.00%
-33.3%
Q4 2016$1,614,000
+16.6%
529,200
+4.0%
0.00%
+50.0%
Q3 2016$1,384,000
-9.4%
508,700
-4.8%
0.00%
-33.3%
Q2 2016$1,528,000
-9.3%
534,200
-4.2%
0.00%0.0%
Q1 2016$1,684,000
-14.4%
557,500
-1.6%
0.00%
-25.0%
Q4 2015$1,967,000
-13.4%
566,800
-5.7%
0.00%
-20.0%
Q3 2015$2,272,000
-36.2%
601,100
-3.8%
0.01%
-37.5%
Q2 2015$3,563,000
+0.5%
625,000
+2.6%
0.01%0.0%
Q1 2015$3,546,000
+4.3%
609,200
+1.6%
0.01%0.0%
Q4 2014$3,400,000
+31.5%
599,719
-5.1%
0.01%
+14.3%
Q3 2014$2,585,000
-23.3%
632,100
-14.6%
0.01%
-12.5%
Q2 2014$3,369,000
+21.6%
740,400
+26.7%
0.01%
+14.3%
Q1 2014$2,771,000
+20.5%
584,574
+19.5%
0.01%
+16.7%
Q4 2013$2,299,000
+4.0%
489,200
+16.4%
0.01%
+20.0%
Q3 2013$2,210,000
+27.5%
420,171
+13.9%
0.01%0.0%
Q2 2013$1,734,000369,0000.01%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q3 2021
NameSharesValueWeighting ↓
AMH Equity Ltd 2,141,353$9,207,81810.12%
B. Riley Asset Management, LLC 3,262,995$14,030,8795.58%
Meros Investment Management, LP 807,117$3,470,6031.89%
Harvey Partners, LLC 2,557,500$10,997,2501.39%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,923,034$12,569,0460.80%
Acuitas Investments, LLC 241,781$1,039,6580.61%
BARD ASSOCIATES INC 285,922$1,229,4650.51%
Riverwater Partners LLC 81,482$350,3730.32%
Archon Capital Management LLC 279,358$1,201,2390.32%
Granahan Investment Management 1,735,572$7,462,9600.27%
View complete list of HARVARD BIOSCIENCE INC shareholders